KNWN - Know Labs, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.5500
-0.1300 (-7.74%)
At close: 3:56PM EDT
Stock chart is not supported by your current browser
Previous Close1.6900
Open1.6900
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.5000 - 1.7400
52 Week Range0.2300 - 5.7500
Volume44,835
Avg. Volume66,980
Market Cap28.066M
Beta (3Y Monthly)4.06
PE Ratio (TTM)N/A
EPS (TTM)-0.2950
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire25 days ago

    Know Labs Bio-RFID™ Platform Technology Identifies Blood Alcohol Levels

    Know Labs, Inc. (KNWN) – a provider of diagnostic solutions, released today a video presentation of its Bio-RFID™ platform technology’s successful identification of blood alcohol levels. In the video presentation, CEO Phil Bosua not only discusses the Company’s use of Bio-RFID to detect blood alcohol levels, but the broad implications for its technology platform. “Over the last month we’ve been powering through a ton of experiments and innovations and are really happy to report we’ve now got an AI based algorithm that allows our technology to detect blood alcohol levels non-invasively.

  • Business Wire2 months ago

    Know Labs Releases White Paper Detailing Experimental Results of their Bio-RFID™ Technology

    Know Labs, Inc. (KNWN) – a provider of diagnostic solutions, released today a white paper detailing the results of an experiment using their Bio-RFID™ technology to detect varying blood-glucose levels in the human body. The experiment utilized a tissue phantom mimicking a blood/skin/muscle ratio of approximately 5%/10%/85% respectively to measure varying amounts of glucose in the blood. The experiment produced successful results with the sensor system showing strong signal response and linearity between the varying glucose levels.

  • Business Wire3 months ago

    Know Labs CEO Phil Bosua Presents Overview of the Company’s Technology and Product Strategy

    Know Labs, Inc. (KNWN) – a provider of diagnostic solutions, released today a video presentation highlighting the Know Labs non-invasive Bio-RFID™ technology and the product pathway for the company’s UBAND™ wearable. In the video presentation Company CEO Phil Bosua discusses the Company’s breakthrough technology, details the product strategy for deploying the technology in to the marketplace and addresses the significant scope of the market opportunity for Know Labs.

  • Business Wire3 months ago

    Know Labs Announces Laboratory Comparison Tests of Its UBAND Non-Invasive Blood Glucose Technology and Abbott Labs FreeStyle Libre

    Know Labs, Inc. , a provider of identification, authentication and diagnostic solutions, released today a video overview of comparison tests of the Company’s invention of its UBAND™ wearable to detect blood glucose non-invasively and Abbott Labs FreeStyle Libre.

  • Business Wire5 months ago

    Know Labs Announces Bio-RFID™ Product Platform

    Know Labs, Inc. (KNWN) – a provider of diagnostic solutions, released today a video highlighting the Company’s product pathway and platform. In the video CEO Phil Bosua discusses the Company’s Bio-RFID™ technological breakthrough and the plans for bringing the technology to market.

  • James Anderson, MD, Joins Know Labs as Medical Director
    Business Wire6 months ago

    James Anderson, MD, Joins Know Labs as Medical Director

    Know Labs, Inc. (KNWN) – the developer of the calorie counter UBAND™ wearable and its underlying non-invasive continuous glucose monitoring technology, announced today that James Anderson, MD, has joined the Company as Medical Director. Dr. Anderson will also serve as Chairman of the Company’s Medical, Scientific and Regulatory Affairs Advisory Board. Phil Bosua, Know Labs CEO, stated, “Dr. Anderson immediately understood the science underlying our technology, and shares our vision for its application to medical diagnostics and therapeutics.

  • Know Labs Announces UBAND™ Calorie Counter Wristband
    Business Wire7 months ago

    Know Labs Announces UBAND™ Calorie Counter Wristband

    Know Labs, Inc. (KNWN) – a provider of identification, authentication and diagnostic solutions, published an advertisement in the Seattle Times newspaper today announcing its UBAND™ real time wearable calorie counter wrist band. The Calorie Counter UBAND is built upon the Company’s recent invention that detects blood glucose non-invasively. Know Labs, Inc. (f/k/a Visualant Incorporated) is a public company whose shares currently trade under the stock symbol “KNWN.” The company’s technology directs structured light or radio waves through a substance or material to capture a unique molecular signature.

  • Business Wire7 months ago

    Know Labs Announces Laboratory Comparison Tests of its Non-Invasive Blood Glucose Technology and the DexCom G5®

    Know Labs, Inc. (KNWN) – a provider of identification, authentication and diagnostic solutions, released today a video overview of comparison tests of the Company’s invention of a new way to detect blood glucose non-invasively and the DexCom G5®. In the video, Company CEO Phil Bosua discusses the breakthrough and highlights a comparison of the Know Labs Bio-RFID™ technology with an industry leading continuous glucose monitor from DexCom, Inc. (DXCM). “We’ve just invented a holy grail of the bio-tech industry – non-invasive – blood glucose monitoring.

  • Business Wire8 months ago

    Know Labs Invents New Way to Detect Blood Glucose - Non-invasively

    Know Labs, Inc. (f/k/a Visualant, Incorporated) (KNWN) – a provider of identification, authentication and diagnostic solutions, released today a video of the Company’s invention of a new technology to detect blood glucose non-invasively. In the video, Company CEO Phil Bosua briefly discusses the breakthrough. “We’re developing a brand-new technology platform that measures blood glucose - non-invasively.

  • Business Wire10 months ago

    Know Labs Appoints Michael Grabham Chief Business Officer

    Know Labs, Inc. (f/k/a Visualant, Incorporated) (KNWN) – a provider of identification, authentication and diagnostic solutions, announced today that Michael Grabham has been appointed Chief Business Officer of the Company. Michael Grabham is a Seattle serial entrepreneur who has started six companies over the past 25 years. Grabham has led, as President, several companies from a regional telecommunications company ($14M annual sales) to a software assessment company (startup).